Inventor

MUHN HANS-PETER

DE16 patents

⚠️ This page may combine multiple inventors who share the name “MUHN HANS-PETER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHERING AG

6 patents

US6548534B2Apr 15, 2003

KLAR ULRICH

3 patents

US8623850B2Jan 7, 2014

15, 16-methylene-17-(1′-propenyl)-17,3′-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative

KLAR ULRICH1 citations50

US8937058B2Jan 20, 2015

17-hydroxy-19-nor-21-carboxylic acid-steroid γ-lactone derivative, use thereof, and medicament containing the derivative

KLAR ULRICH0 citations49

US9034856B2May 19, 2015

17-(1′propenyl)-17-3′-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative

KLAR ULRICH0 citations39

BAYER SCHERING PHARMA AG

2 patents

US7846917B2Dec 7, 2010

18-Methyl-19-norandrost-4-ene 17, 17-spiro ether (18-methyl-19-nor-20-spirox-4-en-3-one), and pharmaceutical products comprising the same

BAYER SCHERING PHARMA AG4 citations59

US7262023B2Aug 28, 2007

Microbiological process for the production of 7-substituted 11-hydroxy steroids, 7,17-substituted 11-Halogen steroids and uses thereof

BAYER SCHERING PHARMA AG0 citations49

ZENTARIS AG

1 patent

US7122570B2Oct 17, 2006

Tetrahydrocarbazol derivatives as ligands for G-protein-coupled receptors (GPCR)

ZENTARIS AG21 citations75

KUHNKE JOACHIM

1 patent

US8207150B2Jun 26, 2012

17β-cyano-19-nor-androst-4-ene derivative, its use and medicaments comprising the derivative

KUHNKE JOACHIM1 citations44

BOHLMANN ROLF

1 patent

US8445469B2May 21, 2013

18-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter

BOHLMANN ROLF0 citations43

SCHERING AKITENGESELLSCHAFT

1 patent

US5973172AOct 26, 1999

14-α,17-α-C2 -bridged norprogesterone derivatives

SCHERING AKITENGESELLSCHAFT0 citations43

BAYER IP GMBH

1 patent

US8987239B2Mar 24, 2015

19-nor-steroid derivatives with a 15α,16α-methylene group and a saturated 17,17-spirolactone ring, use thereof, and medicaments containing said derivatives

BAYER IP GMBH0 citations39

MUHN HANS-PETER

SCHERING AG

Nonsteroidal gestagens

Nonsteroidal gestagens

Nonsteroidal gestagens

14α, 17α-C2 -bridged norprogesterone derivatives

14-α, 17-α-C2 bridged norprogesterone derivatives

8β-vinyl-11β-(ω-substituted)alkyl-estra-1,3,5(10)-trienes

KLAR ULRICH

15, 16-methylene-17-(1′-propenyl)-17,3′-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative

17-hydroxy-19-nor-21-carboxylic acid-steroid γ-lactone derivative, use thereof, and medicament containing the derivative

17-(1′propenyl)-17-3′-oxidoestra-4-en-3-one derivative, use thereof, and medicament containing said derivative

BAYER SCHERING PHARMA AG

18-Methyl-19-norandrost-4-ene 17, 17-spiro ether (18-methyl-19-nor-20-spirox-4-en-3-one), and pharmaceutical products comprising the same

Microbiological process for the production of 7-substituted 11-hydroxy steroids, 7,17-substituted 11-Halogen steroids and uses thereof

ZENTARIS AG

Tetrahydrocarbazol derivatives as ligands for G-protein-coupled receptors (GPCR)

KUHNKE JOACHIM

17β-cyano-19-nor-androst-4-ene derivative, its use and medicaments comprising the derivative

BOHLMANN ROLF

18-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter

SCHERING AKITENGESELLSCHAFT

14-α,17-α-C2 -bridged norprogesterone derivatives

BAYER IP GMBH

19-nor-steroid derivatives with a 15α,16α-methylene group and a saturated 17,17-spirolactone ring, use thereof, and medicaments containing said derivatives